Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada
Background In British Columbia, antiretrovirals (ARVs) for HIV treatment (HIV-Tx) and pre-exposure prophylaxis (PrEP) are free-of-charge through publicly-funded Drug Treatment Programs (DTPs). When available, less costly generics are substituted for brand-name ARVs. We describe the incidence and typ...
שמור ב:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publishing
2024-02-01
|
| סדרה: | Antiviral Therapy |
| גישה מקוונת: | https://doi.org/10.1177/13596535241233128 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
